Search
Loading search results...
Search Results for "Drug Company Eli Lilly Misses on Earnings but Beats on Revenue"
Eli Lilly beats on Q2 revenue and profit driven by 'a collection' of name brand drug sales: Analyst
Eli Lilly CEO reacts to Q3 earnings miss, provides pipeline update
Eli Lilly beats on Q3 earnings, cites diabetes drug demand
Eli Lilly CEO David Ricks explains Q1 earnings miss, lowered forecast
Eli Lilly CEO David Ricks breaks down second-quarter earnings and drug pipeline
Pfizer beats estimates, Eli Lilly cuts outlook
Eli Lilly posts top and bottom line beats
Merck, Eli Lilly stocks fall over earnings, outlook concerns
People are 'scratching and clawing' for negative narrative around obesity drugs: Mizuho's Jared Holz
Jim Cramer Reveals the Top Drug Stock for 2025—and It’s Not Eli Lilly!
Eli Lilly CEO on Q2 earnings and core business performance
Eli Lilly CEO on the political heat over drug pricing